Does BLINATUMOMAB Cause Therapy partial responder? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Therapy partial responder have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.5% of all adverse event reports for BLINATUMOMAB.
45
Reports of Therapy partial responder with BLINATUMOMAB
0.5%
of all BLINATUMOMAB reports
30
Deaths
4
Hospitalizations
How Dangerous Is Therapy partial responder From BLINATUMOMAB?
Of the 45 reports, 30 (66.7%) resulted in death, 4 (8.9%) required hospitalization, and 4 (8.9%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLINATUMOMAB. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does BLINATUMOMAB Cause?
Pyrexia (1,064)
Acute lymphocytic leukaemia recurrent (977)
Cytokine release syndrome (952)
Off label use (590)
Death (588)
Neurotoxicity (530)
Drug ineffective (345)
Headache (335)
Neutropenia (265)
Febrile neutropenia (262)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which BLINATUMOMAB Alternatives Have Lower Therapy partial responder Risk?
BLINATUMOMAB vs BLONANSERIN
BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLINATUMOMAB vs BOCEPREVIR
BLINATUMOMAB vs BOCOCIZUMAB
BLINATUMOMAB vs BONIVA